Core Scientific (CORZ) reported a Q4 net loss late Wednesday of $0.60 per diluted share, widening from a loss of $0.51 a year earlier.
Analysts polled by FactSet expected a loss of $0.09.
Revenue for the quarter ended Dec. 31 was $94.9 million, down from $141.9 million a year earlier. Analysts surveyed by FactSet expected $98.8 million.
Shares of the company were up over 10% in after-hours activity.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。